Oscar Health, Inc. 2023 Second Quarter Conference Call

NEW YORK--(BUSINESS WIRE)-- Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, will release its second quarter 2023 financial results after market close on Tuesday, August 8, 2023.

Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows:

• Live Call: (877) 400-4403
• Conference ID: 6577079
• Webcast Link

The call will be archived and available on Oscar’s investor relations website (www.ir.hioscar.com) following August 8, 2023.

About Oscar Health
Oscar Health, Inc. (“Oscar”) is the first health insurance company built around a full stack technology platform and a relentless focus on serving its members. At Oscar, our mission is to make a healthier life accessible and affordable for all. Headquartered in New York City, Oscar has been challenging the health care system's status quo since our founding in 2012. The company’s member-first philosophy and innovative approach to care has earned us the trust of over one million members as of March 31, 2023. We offer Individual & Family, Small Group and Medicare Advantage plans, and +Oscar, our full stack technology platform, to others within the provider and payor space. Our vision is to refactor health care to make good care cost less. Refactor is a term used in software engineering that means to improve the design, structure, and implementation of the software, while preserving its functionality. At Oscar, we take this definition a step further. We improve our members’ experience by building trust through deep engagement, personalized guidance, and rapid iteration.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230707691176/en/

For more information, please visit www.hioscar.com.

IR:
Cornelia Miller, Oscar
917-397-0251
[email protected]

MEDIA:
JoAnna DiTullio, Oscar
310-592-8046
[email protected]

Source: Oscar Health, Inc.

You May Also Be Interested In

• Ferguson Wellman Named to CNBC’s Inaugural Elite Advisors List for 2026
• Elevance Health beats estimates but shares fall on margin concerns
• The Precision Peptide Company Inc. Announces Closing of LIFE Offering of Common Shares